<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d570" origId="Coagulation factor VIIa"><sentence id="DrugDDI.d570.s0" origId="s0" text="The risk of a potential interaction between NovoSeven and coagulation factor concentrates has not been adequately evaluated in preclinical or clinical studies."><entity id="DrugDDI.d570.s0.e0" origId="s0.p2" charOffset="44-53" type="drug" text="NovoSeven"/><entity id="DrugDDI.d570.s0.e1" origId="s0.p4" charOffset="58-76" type="drug" text="coagulation factor"/><pair id="DrugDDI.d570.s0.p0" e1="DrugDDI.d570.s0.e0" e2="DrugDDI.d570.s0.e1" interaction="false"/></sentence><sentence id="DrugDDI.d570.s1" origId="s1" text="Simultaneous use of activated prothrombin complex concentrates or prothrombin complex concentrates should be avoided."><entity id="DrugDDI.d570.s1.e0" origId="s1.p14" charOffset="20-61" type="drug" text="activated prothrombin complex concentrate"/><entity id="DrugDDI.d570.s1.e1" origId="s1.p16" charOffset="66-98" type="drug" text="prothrombin complex concentrates"/><pair id="DrugDDI.d570.s1.p0" e1="DrugDDI.d570.s1.e0" e2="DrugDDI.d570.s1.e1" interaction="false"/></sentence><sentence id="DrugDDI.d570.s2" origId="s2" text="Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., tranexamic acid, aminocaproic acid) and NovoSeven."><entity id="DrugDDI.d570.s2.e0" origId="s2.p35" charOffset="170-185" type="drug" text="tranexamic acid"/><entity id="DrugDDI.d570.s2.e1" origId="s2.p36" charOffset="187-204" type="drug" text="aminocaproic acid"/><entity id="DrugDDI.d570.s2.e2" origId="s2.p39" charOffset="210-219" type="drug" text="NovoSeven"/><pair id="DrugDDI.d570.s2.p0" e1="DrugDDI.d570.s2.e0" e2="DrugDDI.d570.s2.e1" interaction="false"/><pair id="DrugDDI.d570.s2.p1" e1="DrugDDI.d570.s2.e0" e2="DrugDDI.d570.s2.e2" interaction="true"/><pair id="DrugDDI.d570.s2.p2" e1="DrugDDI.d570.s2.e1" e2="DrugDDI.d570.s2.e2" interaction="true"/></sentence><sentence id="DrugDDI.d570.s3" origId="s3" text="NovoSeven should not be mixed with infusion solutions until clinical data are available to direct this use."><entity id="DrugDDI.d570.s3.e0" origId="s3.p40" charOffset="0-9" type="drug" text="NovoSeven"/></sentence></document>